Magnetically Immobilized Microbiocidal Enzymes, ZYMtronix, 15th Apr
Summary
The European Patent Office published patent application EP3297442A1 titled 'Magnetically Immobilized Microbiocidal Enzymes' filed by ZYMtronix, Inc. The invention relates to the use of magnetically immobilized microbiocidal enzymes for antimicrobial applications. The patent application was published on 15 April 2026 under EPC procedure, with designated states covering all EU member states plus associated countries.
What changed
The European Patent Office published patent application EP3297442A1 for 'Magnetically Immobilized Microbiocidal Enzymes' filed by ZYMtronix, Inc. (inventor: CORGIE, Stephane). The application is classified under IPC A01N 63/02 and C12N 11/18, covering biotechnological methods for enzyme immobilization with antimicrobial properties.
Affected parties include the applicant ZYMtronix, Inc. seeking European patent protection, potential competitors in the biocatalysis or antimicrobial enzyme space, and licensees interested in commercializing magnetically immobilized enzyme technology. Third parties have the standard opportunity to challenge the patent during the nine-month opposition period following publication.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MAGNETICALLY IMMOBILIZED MICROBIOCIDAL ENZYMES
Publication EP3297442A1 Kind: A1 Apr 15, 2026
Applicants
ZYMtronix, Inc.
Inventors
CORGIE, Stephane
IPC Classifications
A01N 63/02 20060101AFI20181001BHEP C12N 11/18 20060101ALI20181001BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.